APSR2026-618

Yes
Late-Breaking
Submitted
Oral Presentation
AO12-005
 
 
https://storage.unitedwebnetwork.com/files/1285/1220927-46903-APSR-618_440038.pptx
Format: PPTX Only
 
Format: PDF Only
05. Respiratory Infections (non-tuberculous)
13

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Findra Setianingrum * Faculty of Medicine Universitas Indonesia Department of Parasitology Jakarta Indonesia Faculty of Medicine Universitas Indonesia Department of Pulmonology and Respiratory Medicine Jakarta Indonesia Indonesia Pulmonary Mycoses Centre Indonesia Pulmonary Mycoses Centre Jakarta Indonesia
Anna Rozaliyani - Faculty of Medicine Universitas Indonesia Department of Parasitology Jakarta Indonesia Indonesia Pulmonary Mycoses Centre Indonesia Pulmonary Mycoses Centre Jakarta Indonesia Grha Permata Ibu Hospital Department of Pulmonology and Respiratory Medicine Depok Indonesia
Robiatul Adawiyah - Faculty of Medicine Universitas Indonesia Department of Parasitology Jakarta Indonesia
Cut Yulia Indah Sari - Jakarta Islamic Hospital Department of Pulmonology and Respiratory Medicine Jakarta Indonesia
Finny Nandipinto - Indonesia Pulmonary Mycoses Centre Indonesia Pulmonary Mycoses Centre Jakarta Indonesia
Johannes Ramnath - Faculty of Medicine Universitas Kristen Indonesia Department of Pulmonology and Respiratory Medicine Jakarta Indonesia
Ammar Abdurrahman Hasyim - Faculty of Medicine Universitas Indonesia Department of Parasitology Jakarta Indonesia Indonesia Pulmonary Mycoses Centre Indonesia Pulmonary Mycoses Centre Jakarta Indonesia
Diah Handayani - Faculty of Medicine Universitas Indonesia Department of Pulmonology and Respiratory Medicine Jakarta Indonesia
Arief Riadi Arifin - MH Thamrin Hospital Department of Pulmonology and Respiratory Medicine Jakarta Indonesia
Erlina Burhan - Faculty of Medicine Universitas Indonesia Department of Pulmonology and Respiratory Medicine Jakarta Indonesia
Retno Wahyuningsih - Faculty of Medicine Universitas Indonesia Department of Parasitology Jakarta Indonesia
Riina Rautemaa-Richardson - Manchester University NHS Foundation Trust National Aspergillosis Centre and the Department of Infectious Diseases Manchester United Kingdom Faculty of Biology, Medicine and Health, University of Manchester Manchester Fungal Infection Group Manchester United Kingdom
David W Denning - Manchester University NHS Foundation Trust National Aspergillosis Centre and the Department of Infectious Diseases Manchester United Kingdom Faculty of Biology, Medicine and Health, University of Manchester Manchester Fungal Infection Group Manchester United Kingdom
 
 
Presenting Author Details
Findra
Setianingrum
dr.findra@gmail.com
+6285892386015
31-40
Indonesia
Original Research
The role of Aspergillus immunoglobulin G in the diagnosis of Chronic Pulmonary Aspergillosis: results of a multicenter Indonesian study
Maximum 25 words
Abstract Content
Chronic pulmonary aspergillosis (CPA) can occur as a complication during recovery from pulmonary tuberculosis (TB). There is limited information regarding the emergence of CPA during TB treatment and the possible coexistence of active TB and CPA. Despite Indonesia’s high TB burden, prospective studies on CPA remain scarce. Therefore, this study aims to determine the role of Aspergillus IgG measurement and impact of CPA in the quality of life of patients.
This prospective, longitudinal cohort study examined patterns of Aspergillus IgG and quality of life and CPA rates in pulmonary TB patients. Patients completed questionnaires at start of TB therapy, at the end of TB therapy, and post TB therapy. Serum Aspergillus-specific IgG level was measured using Siemens Immulite 2000 system (cutoff 11.5 mg/l). Questionnaires were repeated at each patient’s visit to hospital. CPA was diagnosed on the basis of symptoms for >3 months, characteristic radiological features and positive Aspergillus serology.
There were 216 patients available for data analysis at baseline, 128 patients with baseline and the end of therapy data, and 67 patients had data for all three time-points. Median Aspergillus IgG level post TB increased between baseline (8.1 IQR 6.3-11.5 mg/l) and post-TB therapy (11.4 IQR 7.9-16.4 mg/l) (p=0.001) in 67 patients. Overall SGRQ scores as well as sub points of SGRQ symptoms, impact and activity dropped significantly in all (n=67) patients across three time points (p<0.001), SGRQ scores in CPA patients were higher than in non-CPA patients (p=0.005).
CPA should be considered as a differential diagnosis in TB patients in Indonesia. Lack of awareness of CPA and limited access to Aspergillus IgG tests is obstacle in establishing CPA diagnosis. Active diagnostics for CPA is required during TB therapy to increase the quality of life of patients with proper therapy of CPA.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Aspergillus IgG, aspergillosis, quality of life.
maximum 3 keywords and no abbreviations, separated by commas
 
310